Zaki Shannak

Zaki Shannak

Auto-generated profile, based on publicly available information

Zaki Shannak

Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
NANoor M. Alqudah
Noor M. Alqudah
HJHisham M Jammal
Hisham M Jammal
Yousef KhaderYousef Khader
Yousef Khader
WAWedad Al-Dolat
Wedad Al-Dolat
SASarah Alshamarti
Sarah Alshamarti
ZSZaki Shannak
Zaki Shannak
Purpose: To study the demographic, clinical and topographic characteristics of keratoconus patients in Jordan. Methods: A retrospective study which was conducted at King Abdullah University Hospital, Northern Jordan. The patients who visited our outpatient clinic from March 2015 to September 2020 and had a definite diagnosis of keratoconus were included in this study. Demographic and clinical data, including age, gender, family history, past ocular history, ophthalmic examination, and topographic parameters, were collected and analysed. Keratoconus severity was classified according to K mean readings. Results: A total of 234 patients with keratoconus were evaluated in this study. The majority of patients (73, 31.2%) were between the ages of 20 and 24. Allergic conjunctivitis was the most frequent past ocular history. Fifty-five patients (23.5%) had a family history of keratoconus. Regarding severity, most of the eyes were mild (63.3%), followed by moderate (24.7%), and then severe (11.9%). The severity of keratoconus was significantly associated with gender (p< 0.001). No correlation was found between family history and severity. Conclusion: Most of the Keratoconus patients were young, with a mean age of 25.9 years. The majority were mild in severity, with more females presented in the severe stage. The study reported high rate of family history (23.5%) in comparison to similar studies. Therefore, screening of family members of Keratoconus patients is advisable.

1 November 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
RARami Al-Dwairi
Rami Al-Dwairi
WSWisam A Shihadeh
Wisam A Shihadeh
AAAsem A. Alqudah
Asem A. Alqudah
NANoor M. Alqudah
Noor M. Alqudah
MMMohammed Msallam
Mohammed Msallam
AAAbdelwahab Aleshawi
Abdelwahab Aleshawi
Objective: The management of ocular complications of Marfan’s syndrome, especially ectopia lentis, is challenging. In this study, we present the effectiveness and the safety of iris-claw intraocular lens (IOL) implantation along with lensectomy for those patients. Also, we compare the practice of implanting these IOLs either in the anterior chamber of retropupillary. Methods: Retrospectively, we included all patients with Marfan’s syndrome who underwent lensectomy with iris-claw IOL implantation as a result of ectopia lentis. The patients were categorized into two groups: anterior chamber iris claw IOL and retropupillary iris-claw IOL. The clinical and demographic data, the visual outcome and postoperative complications were compared. Results: Eighteen eyes of 10 patients were included in the study. The mean age of the patients was 19.1 years. Six patients were males. The iris-claw IOL was implanted anteriorly in 13 eyes. The visual outcome was comparable between both groups and most patients achieved improvement in the visual acuity. In addition, the postoperative complications developed similarly in both groups. However, all cases of IOL disenclavation (6 cases) developed in the anterior group. It is revealed that the age of the patient was the most significant factor affecting the occurrence of IOL disenclavation. Conclusion: Iris-claw IOL (either anteriorly or retropupillary) is an effective and relatively safe method in treating ectopia lentis in patients with Marfan’s syndrome. In younger patients, anterior iris-claw IOL is safer than retropupillary iris-claw IOL as the risk of disenclavation is higher in younger patients.

1 August 2025 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
HJHisham M Jammal
Hisham M Jammal
RARami Al-omari
Rami Al-omari
ZSZaki Shannak
Zaki Shannak
SAShadi Alkhatib
Shadi Alkhatib
Hashem Abu SerhanHashem Abu Serhan
Hashem Abu Serhan
Objective: To assess the long-term surgical outcome and complications in patients who underwent pterygium excision with conjunctival limbal autograft at least 11 years after surgery in a country with high ultraviolet light exposure. Material and Methods: This was a long-term, cross-sectional, observational follow-up study of 15 patients with primary or recurrent pterygium who underwent surgery at King Abdullah University Hospital, Jordan, between June 2005 and June 2012. Data regarding the patients’ satisfaction with the results, use of protective sunglasses, and daily sunlight exposure over the long-term period after surgery were collected. Recruited patients were then examined for pterygium recurrence and graft bed cosmesis. Primary outcome was the recurrence rate of pterygium. Secondary outcomes included graft bed appearance (cosmesis), patient-reported satisfaction, and long-term postoperative complications. Results: The mean (SD) age of the patients at the follow-up was 50 (8.8) years (range: 34– 66 years), and the mean (SD) follow-up duration was 13.1 (1.5) years (range: 11– 16 years). There was one case of recurrence (6.7%) and one case of symblepharon at the harvested graft site. Eleven out of the 15 patients reported being completely satisfied with the outcome of the surgery (mean score of 9.7 out of 10, SD: 1.0, range: 7– 10). Seven patients reported daily sunlight exposure of more than three hours, and most of them were not regular users of protective sunglasses. Conclusion: The long-term follow-up, pterygium excision with conjunctival limbal autograft was found to be safe and effective in a country with high ultraviolet exposure.